The University of Florida annually recognizes outstanding young alumni with its 40 Gators Under 40 awards. In 2022, three UF College of Pharmacy graduates were honored based on their contributions professionally and to their communities.

Patricia Louzon
Pharm.D. ’07

Patricia Louzon, Pharm.D., serves as a clinical manager in the critical care and emergency department at AdventHealth Central Florida in Orlando. She received her Doctor of Pharmacy from the UF College of Pharmacy in 2007 and completed PGY1 and PGY2 critical care residencies at Orlando Health. She joined AdventHealth in 2009 and has more recently been leading COVID-19 response efforts in the intensive care unit. As a clinical assistant professor in the UF College of Pharmacy, she provides lectures and facilitates an elective course in critical care. She regularly precepts pharmacy students and has been previously named Preceptor of the Year. Louzon serves as a committee chair for the Society of Critical Care Medicine, where she has received Presidential Citations for her contributions in various roles. In 2020, she was awarded Fellowship status in the American College of Critical Care Medicine for demonstrating significant contributions to the critical care profession at regional, state and national levels.

Donna Rivera
Pharm.D. ’12, M.Sc. ’14

Donna Rivera, Pharm.D., M.Sc., is the associate director for pharmacoepidemiology in the Oncology Center of Excellence at the U.S. Food and Drug Administration. She leads the Oncology Real World Evidence, or RWE, Program, focused on the use of real-world data and RWE for regulatory purposes, as well as management of the real-world data research portfolio strategy and development of regulatory policy to support the Oncology Center of Excellence mission. As a pharmacist and pharmacoepidemiologist, Rivera’s interests include the use of real-world data to advance health equity, observational study designs and methodological approaches, and appropriate uses of real-world data for drug development to increase access to effective therapies for patients. She has published more than 40 peer-reviewed publications and presented at more than 45 scientific conferences. Rivera earned her Doctor of Pharmacy and a Master of Science in Pharmaceutical Sciences with a concentration in pharmaceutical outcomes and policy from the UF College of Pharmacy.

Mohamed Shahin
Ph.D. ’15, M.S. ’18

Mohamed Shahin, Ph.D., M.S., currently works as a clinical pharmacology lead in global product development at Pfizer. He completed a Ph.D. in clinical pharmaceutical sciences from the UF College of Pharmacy in 2015, followed by a three-year fellowship in cardiovascular pharmacogenomics and precision medicine at the UF College of Pharmacy and another fellowship in informatics at the UF Informatics Institute. He also holds a master’s degree in Biomedical Informatics from the UF College of Medicine. Over the past 10 years, he led several research projects, both in academia and the pharmaceutical industry, to optimize drug response for patients with complex diseases and support drug development in different therapeutic areas. He has contributed to the field of clinical pharmacology and precision medicine by publishing several research articles in high-impact journals like The Lancet, Clinical Pharmacology and Therapeutics, and Hypertension as well as chairing several workshops and symposiums in national and international scientific meetings.